Abstract:The antiviral endoribonuclease, RNase L, is activated by the mammalian innate immune response to destroy host and viral RNA to ultimately reduce viral gene expression. Herein, we show that RNase L and RNase L-mediated mRNA decay are primarily localized to the cytoplasm. Consequently, RNA-binding proteins (RBPs) translocate from the cytoplasm to the nucleus upon RNase L activation due to the presence of intact nuclear RNA. The re-localization of RBPs to the nucleus coincides with global alterations to RNA processing in the nucleus. While affecting many host mRNAs, these alterations are pronounced in mRNAs encoding type I and type III interferons and correlate with their retention in the nucleus and reduction in interferon protein production. Similar RNA processing defects also occur during infection with either dengue virus or SARS-CoV-2 when RNase L is activated. These findings reveal that the distribution of RBPs between the nucleus and cytosol is dictated by the availability of RNA in each compartment. Thus, viral infections that trigger RNase L-mediated cytoplasmic RNA in the cytoplasm also alter RNA processing in the nucleus, resulting in an ingenious multi-step immune block to protein biogenesis. Ribonuclease L (RNase L) initiates rapid and widespread degradation of cellular mRNAs in response to double-stranded RNA or viral infection. How the mass degradation of mRNAs affects cellular functions is unknown. Herein, we show that RNase L-mediated mRNA decay is predominately localized to the cytoplasm. Consequently, RNA-binding proteins re-localize from the cytoplasm to the nucleus upon RNase L activation. Coinciding with the influx of RNA-binding proteins into the nucleus, we also observe perturbation of nuclear processing of mRNAs, and these processing defects down-regulate key antiviral cytokines, such as type I interferons. Importantly, we observe these processes occurring during dengue virus and SARS-CoV-2 infection, revealing previously unknown aspects of antiviral gene regulation during pathogenic viral infections. Combined, these findings uncover novel mechanisms by which RNase L regulates host gene expression and expand the potential means by which RNase L blocks protein synthesis.

Initiation of a ZAKα-dependent ribotoxic stress response by the innate immunity endoribonuclease RNase L

Endonucleolytic RNA cleavage drives changes in gene expression during the innate immune response

The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc

RNase L activates the NLRP3 inflammasome during viral infections

The ribotoxic stress response drives UV-mediated cell death

Z-form nucleic acid-binding protein 1 (ZBP1) as a sensor of viral and cellular Z-RNAs: walking the razor's edge

Overexpression of the Transcription Factor Sp1 Activates the OAS-RNAse L-RIG-I Pathway

Triggering endogenous Z-RNA sensing for anti-tumor therapy through ZBP1-dependent necroptosis

Z-nucleic acid sensor ZBP1 in sterile inflammation

RNA Helicase SKIV2L Limits Antiviral Defense and Autoinflammation Elicited by the OAS-RNase L Pathway

An atypical E3 ligase safeguards the ribosome during nutrient stress

JNK Activation Turns on LPS- and Gram-Negative Bacteria-Induced NADPH Oxidase-Dependent Suicidal NETosis

Ribotoxic stress drives cell death by UV

Regulation of antiviral innate immune signaling by stress-induced RNA granules

An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity

RNA Viruses Promote Activation of the NLRP3 Inflammasome Through a RIP1-RIP3-DRP1 Signaling Pathway

Condensation of RNase L promotes its rapid activation in response to viral infection in mammalian cells

Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1

Mechanistic basis for potassium efflux-driven activation of the human NLRP1 inflammasome

RNase L activation in the cytoplasm induces aberrant processing of mRNAs in the nucleus

The ribotoxic stress response drives acute inflammation, cell death, and epidermal thickening in UV-irradiated skin in vivo